Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Hsin Chen

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Scientific Reports|November 10, 2017
The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer CellsShang-Ru Wu, Chen-Hsin Teng, Ya-Ting Tu, et al.
Surgical Endoscopy|October 30, 2021
Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration GroupChih-Chin Yu, Chung-Hsin Chen, Jian-Hua Hong, et al.
Scientific Reports|February 14, 2020
Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer CellsShang-Ru Wu, Chen-Hsin Teng, Ya-Ting Tu, et al.
Scientific Reports|August 1, 2024
No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomyTsu-Chen Lin, Guan-Heng Chen, Chin-Chung Yeh, et al.
Urologic Oncology|March 23, 2020
Acrolein contributes to urothelial carcinomas in patients with chronic kidney diseaseJian-Hua Hong, Priscilla Ann Hweek Lee, Yu-Chuan Lu, et al.
Japanese Journal of Clinical Oncology|March 1, 2022
Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysisNobuaki Matsubara, Kazuo Nishimura, Satoru Kawakami, et al.
Scientific Reports|July 21, 2022
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancerYu-Cheng Lu, Chao-Yuan Huang, Chia-Hsien Cheng, et al.
Kidney International|October 11, 2021
Loss of proximal tubular transcription factor Krüppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidationSian E Piret, Ahmed A Attallah, Xiangchen Gu, et al.
Science Translational Medicine|August 9, 2013
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencingMargaret L Hoang, Chung-Hsin Chen, Viktoriya S Sidorenko, et al.
Cancer Research and Treatment|June 27, 2025
Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 StudySe Hoon Park, Yen-Hwa Chang, Jae Lyun Lee, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Scientific Reports|November 10, 2017
The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer CellsShang-Ru Wu, Chen-Hsin Teng, Ya-Ting Tu, et al.
Surgical Endoscopy|October 30, 2021
Comparison of oncological outcomes for hand-assisted and pure laparoscopic radical nephroureterectomy: results from the Taiwan Upper Tract Urothelial Cancer Collaboration GroupChih-Chin Yu, Chung-Hsin Chen, Jian-Hua Hong, et al.
Scientific Reports|February 14, 2020
Author Correction: The Kunitz Domain I of Hepatocyte Growth Factor Activator Inhibitor-2 Inhibits Matriptase Activity and Invasive Ability of Human Prostate Cancer CellsShang-Ru Wu, Chen-Hsin Teng, Ya-Ting Tu, et al.
Scientific Reports|August 1, 2024
No difference in oncological outcomes and perioperative complications between patients with ESRD with unilateral and bilateral UTUC receiving radical nephroureterectomyTsu-Chen Lin, Guan-Heng Chen, Chin-Chung Yeh, et al.
Urologic Oncology|March 23, 2020
Acrolein contributes to urothelial carcinomas in patients with chronic kidney diseaseJian-Hua Hong, Priscilla Ann Hweek Lee, Yu-Chuan Lu, et al.
Japanese Journal of Clinical Oncology|March 1, 2022
Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysisNobuaki Matsubara, Kazuo Nishimura, Satoru Kawakami, et al.
Scientific Reports|July 21, 2022
Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancerYu-Cheng Lu, Chao-Yuan Huang, Chia-Hsien Cheng, et al.
Kidney International|October 11, 2021
Loss of proximal tubular transcription factor Krüppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidationSian E Piret, Ahmed A Attallah, Xiangchen Gu, et al.
Science Translational Medicine|August 9, 2013
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencingMargaret L Hoang, Chung-Hsin Chen, Viktoriya S Sidorenko, et al.
Cancer Research and Treatment|June 27, 2025
Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 StudySe Hoon Park, Yen-Hwa Chang, Jae Lyun Lee, et al.
Pageof 9